The single agent and the combination of apatinib and each cytotoxic drug enhanced cell apoptosis through inhibiting Bcl2 and repressed cell invasion by blocking MMP9 and EMT in ESCC cells. This evidence concerns the gene MMP9 and esophageal squamous cell carcinoma.